Cannabidiol in the Management of In-Patient Cannabis Withdrawal: Clinical Case Series
- 21 July 2017
- journal article
- Published by Taylor & Francis in Future Neurology
- Vol. 12 (3) , 133-140
Abstract
Aim: To assess the feasibility of the use of cannabidiol (CBD) for the management of cannabis withdrawal. Patients & methods: Eight participants were admitted to an in-patient detoxification facility for a 7-day open-label trial of CBD. Five participants received 600 mg of CBD and three participants received 1200 mg of CBD. Participants returned for a 28-day follow-up interview. Results & conclusion: CBD was well tolerated by all participants. Five completed the full treatment period and abstinence was maintained by four participants at day 28 follow-up. All those receiving the higher dose completed treatment and achieved abstinence at follow-up. This pilot study suggests that further exploration of CBD as a pharmacological adjunctive therapy for cannabis withdrawal and dependence is warranted. Registration ACTRN1261400024866.Keywords
Funding Information
- National Cannabis Prevention and Information Centre
This publication has 24 references indexed in Scilit:
- Effects of acute systemic administration of cannabidiol on sleep-wake cycle in ratsJournal of Psychopharmacology, 2013
- Cannabidiol for the treatment of cannabis withdrawal syndrome: a case reportJournal of Clinical Pharmacy and Therapeutics, 2012
- Quantifying the Clinical Significance of Cannabis WithdrawalPLOS ONE, 2012
- The Anxiety Sensitivity Index—RevisedAssessment, 2008
- Cannabis withdrawal predicts severity of cannabis involvement at 1‐year follow‐up among treated adolescentsAddiction, 2008
- The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-offDrug and Alcohol Dependence, 2006
- The cannabis withdrawal syndromeCurrent Opinion in Psychiatry, 2006
- The Cannabis Problems Questionnaire: Factor structure, reliability, and validityDrug and Alcohol Dependence, 2005
- Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability ScaleThe International Journal of Psychiatry in Medicine, 1997
- Self-efficacy and marijuana cessation: A construct validity analysis.Journal of Consulting and Clinical Psychology, 1995